Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

293 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Randomized comparison of DAT versus ADE as induction chemotherapy in children and younger adults with acute myeloid leukemia. Results of the Medical Research Council's 10th AML trial (MRC AML10). Adult and Childhood Leukaemia Working Parties of the Medical Research Council.
Hann IM, Stevens RF, Goldstone AH, Rees JK, Wheatley K, Gray RG, Burnett AK. Hann IM, et al. Among authors: wheatley k. Blood. 1997 Apr 1;89(7):2311-8. Blood. 1997. PMID: 9116274 Free article. Clinical Trial.
Improved outcome of acute myeloid leukaemia in Down's syndrome.
Craze JL, Harrison G, Wheatley K, Hann IM, Chessells JM. Craze JL, et al. Among authors: wheatley k. Arch Dis Child. 1999 Jul;81(1):32-7. doi: 10.1136/adc.81.1.32. Arch Dis Child. 1999. PMID: 10373130 Free PMC article.
Treatment-related deaths during induction and first remission of acute myeloid leukaemia in children treated on the Tenth Medical Research Council acute myeloid leukaemia trial (MRC AML10). The MCR Childhood Leukaemia Working Party.
Riley LC, Hann IM, Wheatley K, Stevens RF. Riley LC, et al. Among authors: wheatley k. Br J Haematol. 1999 Aug;106(2):436-44. doi: 10.1046/j.1365-2141.1999.01550.x. Br J Haematol. 1999. PMID: 10460604 Free article. Clinical Trial.
A simple, robust, validated and highly predictive index for the determination of risk-directed therapy in acute myeloid leukaemia derived from the MRC AML 10 trial. United Kingdom Medical Research Council's Adult and Childhood Leukaemia Working Parties.
Wheatley K, Burnett AK, Goldstone AH, Gray RG, Hann IM, Harrison CJ, Rees JK, Stevens RF, Walker H. Wheatley K, et al. Br J Haematol. 1999 Oct;107(1):69-79. doi: 10.1046/j.1365-2141.1999.01684.x. Br J Haematol. 1999. PMID: 10520026 Free article. Clinical Trial.
293 results